Skip to main content

Table 2 The association between patient characteristics and tumor grade, tumor stage, muscle invasion, and recurrence after 18 month

From: Association of human papilloma virus (HPV) infection with oncological outcomes in urothelial bladder cancer

Variable Age (year) Sex Smoking Family history of cancer
Mean (SD) Male (%) Female (%) Yes (%) No (%) Positive (%) Negative (%)
Tumor Grade
Low grade 62.71 (10.45) 46 (54.10) 13 (61.90) 44 (54.3) 15 (60) 21 (44.70) 38 (64.40)
High grade 63.32 (10.13) 39 (45.90) 8 (38.10) 37 (45.7) 10 (40) 26 (55.30) 21 (35.60)
P-Value 0.764 a 0.520 c 0.617 c 0.042 c
Tumor Stage
Ta 62.02 (9.99) 40 (47.10) 10 (47.60) 38 (46.90) 12 (48.00) 17 (36.20) 33 (55.90)
T1 67.92 (12.57) 10 (11.80) 3 (14.30) 10 (12.30) 3 (12.00) 5 (10.60) 8 (13.60)
T2 65.15 (8.39) 26 (30.60) 7 (33.30) 24 (29.60) 9 (36.00) 21 (44.70) 12 (20.30)
T3-T4 54.20 (9.00) 9 (10.60) 1 (4.80) 9 (11.10) 1 (4.00) 4 (8.50) 6 (10.20)
P-Value 0.005 b 0.865 c 0.734 c 0.060 c
Muscle Invasion
Positive 62.60 (9.64) 35 (41.20) 8 (38.10) 33 (40.70) 10 (40) 25 (53.20) 18 (30.50)
Negative 63.24 (10.73) 50 (58.80) 13 (61.90) 48 (59.30) 15 (60) 22 (46.80) 41 (69.50)
P-Value 0.757 a 0.797 c 0.947 c 0.018 c
Recurrence after 18 months
Positive 60.92 (10.63) 49 (57.60) 12 (57.10) 49 (60.50) 12 (48.00) 36 (76.6) 25 (42.40)
Negative 65.78 (9.13) 36 (42.40) 8 (42.90) 32 (39.50) 13 (52.00) 11 (23.4) 34 (57.60)
P-Value 0.015 a 0.976 c 0.296 c < 0.001 c
  1. a Independent t test; b Analysis of variance (ANOVA); c Chi-square test